PLXNA2
Basic information
Region (hg38): 1:208022242-208244384
Previous symbols: [ "PLXN2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLXNA2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 174 | 12 | 189 | |||
missense | 297 | 11 | 13 | 322 | ||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 5 | 20 | 3 | 28 | ||
non coding | 58 | 16 | 74 | |||
Total | 0 | 1 | 305 | 243 | 41 |
Variants in PLXNA2
This is a list of pathogenic ClinVar variants found in the PLXNA2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-208027253-A-G | not specified • PLXNA2-related disorder | Uncertain significance (Jan 03, 2024) | ||
1-208027270-GAGCTGCTCCACCTTATAAGCC-G | PLXNA2-related disorder | Uncertain significance (Jun 13, 2024) | ||
1-208027295-C-T | PLXNA2-related disorder | Uncertain significance (Jun 12, 2024) | ||
1-208027296-G-A | PLXNA2-related disorder | Uncertain significance (Aug 18, 2023) | ||
1-208027301-C-T | Uncertain significance (Nov 04, 2022) | |||
1-208027304-C-T | PLXNA2-related disorder | Uncertain significance (Sep 24, 2024) | ||
1-208027310-T-A | PLXNA2-related disorder | Uncertain significance (Jun 27, 2022) | ||
1-208027314-C-T | Uncertain significance (Aug 22, 2022) | |||
1-208027317-C-G | not specified | Uncertain significance (Apr 20, 2023) | ||
1-208027330-C-G | PLXNA2-related disorder | Likely benign (Aug 29, 2023) | ||
1-208027332-C-T | Uncertain significance (Mar 29, 2022) | |||
1-208027344-G-A | PLXNA2-related disorder | Likely benign (Apr 17, 2023) | ||
1-208027347-C-T | Likely benign (Jun 24, 2021) | |||
1-208027996-G-T | Likely benign (Dec 02, 2021) | |||
1-208027999-C-T | PLXNA2-related disorder | Likely benign (Aug 20, 2024) | ||
1-208028006-C-T | PLXNA2-related disorder | Likely benign (Nov 23, 2021) | ||
1-208028046-T-C | PLXNA2-related disorder | Uncertain significance (Oct 25, 2022) | ||
1-208028059-G-A | Likely benign (May 18, 2018) | |||
1-208028064-T-G | Uncertain significance (Mar 27, 2023) | |||
1-208028074-C-T | PLXNA2-related disorder • not specified | Uncertain significance (Oct 20, 2022) | ||
1-208028077-C-T | PLXNA2-related disorder | Uncertain significance (Sep 27, 2023) | ||
1-208028078-G-A | PLXNA2-related disorder | Likely benign (Oct 19, 2022) | ||
1-208028086-G-A | PLXNA2-related disorder | Uncertain significance (Aug 25, 2022) | ||
1-208028094-T-C | PLXNA2-related disorder | Uncertain significance (Dec 27, 2023) | ||
1-208028096-G-A | PLXNA2-related disorder | Likely benign (Mar 23, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLXNA2 | protein_coding | protein_coding | ENST00000367033 | 31 | 222079 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000108 | 1.00 | 125702 | 0 | 46 | 125748 | 0.000183 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.93 | 889 | 1.17e+3 | 0.759 | 0.0000756 | 12378 |
Missense in Polyphen | 389 | 594.17 | 0.6547 | 6245 | ||
Synonymous | -0.431 | 514 | 502 | 1.02 | 0.0000340 | 3853 |
Loss of Function | 5.94 | 28 | 88.3 | 0.317 | 0.00000461 | 955 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000365 | 0.000365 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000238 | 0.000220 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000168 | 0.000163 |
Other | 0.000492 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Coreceptor for SEMA3A and SEMA6A. Necessary for signaling by SEMA6A and class 3 semaphorins and subsequent remodeling of the cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration. Class 3 semaphorins bind to a complex composed of a neuropilin and a plexin. The plexin modulates the affinity of the complex for specific semaphorins, and its cytoplasmic domain is required for the activation of down- stream signaling events in the cytoplasm (By similarity). {ECO:0000250, ECO:0000269|PubMed:10520995}.;
- Pathway
- Axon guidance - Homo sapiens (human);Spinal Cord Injury;Ectoderm Differentiation;Developmental Biology;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Sema3A PAK dependent Axon repulsion;Other semaphorin interactions;Semaphorin interactions;Axon guidance;CRMPs in Sema3A signaling
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.424
- rvis_EVS
- -1.48
- rvis_percentile_EVS
- 3.64
Haploinsufficiency Scores
- pHI
- 0.401
- hipred
- Y
- hipred_score
- 0.668
- ghis
- 0.439
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.422
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Plxna2
- Phenotype
- immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); cellular phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- plxna2
- Affected structure
- optic cup
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- somitogenesis;negative regulation of cell adhesion;regulation of cell shape;neural tube development;cerebellar granule cell precursor tangential migration;regulation of cell migration;regulation of GTPase activity;positive regulation of axonogenesis;centrosome localization;pharyngeal system development;limb bud formation;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in axon guidance
- Cellular component
- semaphorin receptor complex;plasma membrane;integral component of plasma membrane
- Molecular function
- protein binding;semaphorin receptor activity;identical protein binding